Emballages intelligents et lutte contre la contrefaçon des médicaments

Philippe DECLERCK, Directeur général de PACKETIS, insiste sur l’importance des emballages intelligents dans la lutte contre la contrefaçon des médicaments. L’emballage, qui revêt une dimension importante dans l’univers pharmaceutique, doit pouvoir remplir des fonctions d’authentification, d’identification et de traçabilité. Le marquage « Seal Vector », visible ou non, répond aux besoins d’authentification des produits sur lequel il est apposé et embarque sa propre technologie permettant ainsi de nombreuses applications, utilisables notamment pour lutter contre les médicaments contrefaits.

GREENBOX: Innovative, Reusable, Recyclable and Fully Sustainable

GREENBOX benefits the pharmaceutical and life science industries in several ways, for example:

• No spoilage: In the past, shipping temperature-sensitive goods internationally, cross-country or even to outlying or rural areas has resulted in enormous amounts of product spoilage. Because GREENBOX maintains a consistent temperature for up to five days, the risk of spoilage is now virtually non-existent.
• Any-day shipping: The majority of temperature-sensitive goods are shipped overnight express due to limited thermal protection with current shipping technology. Because GREENBOX maintains temperature for up to five days, customers can ship road freight – even on Fridays – typically resulting in a 65 percent reduction in shipping and distribution expenses.
• Greater payload efficiency: GREENBOX offers twice the payload space over competitors because of its innovative and streamlined thermal management system – nanotechnology combined with optimal amounts of phase change material.
• Reduction in distribution-related expenses: Customers can save up to 65 percent on distribution-related expenses due to GREENBOX’s unique, reusable design. In contrast with typical single-use systems, GREENBOX can be reused again and again, with current customers experiencing up to 50 times of reuse.
• Instant-pack protocol: GREENBOX features an instant-pack protocol – a simple five-step process allowing customers the ability to pack payload at its specified temperature without thermal shock.
• The first reusable shipper: Because of the resilient nature of GREENBOX customers can use one box up to 50 times, making it the industry’s first reusable thermal shipper. In the United States (and soon in Europe), reclamation centres gather used GREENBOXes, then inspect, clean and re-certify them for re-use.
• Sustainability: GREENBOX’s innovative materials used are also 100 percent recyclable. When the bright green, hard plastic outer shell and Thermal-LokTM insulating panels reach the end of their lives they are ground down and made into new shells and panels. In addition, GREENBOX features biodegradable, non-petroleum, non-toxic phase change materials.
• Meets “green” initiatives: Many of today’s leading pharmaceutical companies employ green initiatives and GREENBOX is a perfect fit. It’s the industry’s first and only completely sustainable thermal packaging system, created with 100 percent recyclable, organic-based, non-toxic and fully biodegradable components.
  
  

Case study – Walmart’s New Pharma Packaging Survives High Temperatures and Cuts Costs

----

DSM invests in intelligent packaging

DSM Venturing, the corporate venturing unit of Royal DSM N.V., announces that it has made an equity investment in The Compliers Group International B.V. (TCG). The Netherlands-based company focuses on the development of smart pharmaceutical packaging solutions that contain microchips which enable the monitoring of a patient’s therapy compliance.

TCG’s smart packaging solutions can be applied in any existing standard medication blister and will record when a pill has been removed from the blister. This information can be read out wirelessly (e.g. with a mobile phone) and made available to caregivers and patients in day-to-day medication therapy or to pharmaceutical companies or research organizations in clinical studies.

The system will help both patients and volunteers taking part in clinical studies to take their pills at the right time. Caregivers and pharmaceutical companies will be able to better diagnose or judge the effectiveness of medication. This can help to substantially reduce healthcare costs.

First proof of concept of TCG’s “Objective therapy Compliance Measurement” (OtCM®) technology has been obtained. TCG also applies its technology in projects with Ministries of Health, health insurers and others, such as research organizations.

Tony de Vrught, Vice President DSM Specialty Packaging says: “ Intelligent packaging systems aimed at improving patient adherence could substantially contribute to decreasing overall healthcare costs in the future as they reduce the need for more costly interventions. I see this as a logical step forward in combining our knowledge of Life Sciences and Materials Sciences opening up interesting perspectives in innovative packaging applications. I look forward to working with TCG to develop innovative solutions for this market.”

Jos Geboers and Willem Kort, Founders and Managing Directors of TCG: “ This partnership with DSM will help us to refine our product and market development path. Our combined capabilities will accelerate the global implementation of our products, technologies and services as DSM has unique knowledge in both Life Sciences and Materials Sciences.”

Press Release
---